12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ADXS-HPV: Phase I/II started

Advaxis said Cancer Research UK began the U.K. Phase I/II REALISTIC trial to evaluate ADXS-HPV in up to 45...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >